Kimberly-Clark Corporation (NYSE: KMB) has faced a challenging year. The stock trades near $120/share, down about 17% over the past twelve months as weak volumes, higher costs, and softer consumer demand pressured results.
Recently, the company launched its “Bright Futures” global innovation program aimed at driving growth through new product launches across its Huggies and Kleenex brands. Kimberly-Clark also reaffirmed its 2025 cost savings target of $500 million, part of an ongoing effort to boost efficiency and protect margins amid slower sales. These moves show management’s focus on stabilizing performance and reaccelerating growth in its core categories.
This article explores where Wall Street analysts think Kimberly-Clark could trade by 2027. We’ve reviewed consensus price targets and valuation models to outline the stock’s potential path. These figures reflect current analyst expectations and are not TIKR’s own predictions.
Unlock our Free Report: 5 AI compounders that analysts believe are undervalued and could deliver years of outperformance with accelerating AI adoption (Sign up for TIKR, it’s free) >>>
Analyst Price Targets Suggest Modest Upside
Kimberly-Clark trades near $120/share today. The average analyst price target is around $138/share, which points to roughly 15% upside. Forecasts are relatively close together, suggesting that analysts see the stock as fairly valued.
- High estimate: ~$162/share
- Low estimate: ~$113/share
- Median target: ~$140/share
- Ratings: 4 Buys, 2 Outperforms, 13 Holds, 1 Underperform, 1 Sell
It looks like Wall Street expects modest gains ahead but not a major rebound. For investors, that means KMB could deliver steady income but limited capital appreciation unless sales momentum improves.
See analysts’ growth forecasts and price targets for Kimberly-Clark (It’s free!) >>>
Kimberly-Clark: Growth Outlook and Valuation
The company’s fundamentals remain stable but subdued:
- Revenue is projected to decline ~4.9% annually through 2027
- Operating margins are expected to stay around ~17%
- Shares trade at ~16x forward earnings, roughly in line with historical averages
- Based on analysts’ average estimates, TIKR’s Guided Valuation Model using a 15.6x forward P/E suggests ~$118/share by 2027
- That implies about a (1.3%) total return, or roughly (0.6%) annualized
These figures point to a company that’s steady but not expanding. While the balance sheet and dividend remain solid, the stock looks fully valued given its slow growth profile.
For investors, Kimberly-Clark offers dependable income and low volatility, but not much in the way of upside unless management can reignite demand or unlock new cost savings.
Value stocks like Kimberly-Clark in as little as 60 seconds with TIKR (It’s free) >>>
What’s Driving the Optimism?
Kimberly-Clark’s global brands remain its strongest advantage. Products like Huggies, Kleenex, and Cottonelle continue to command strong shelf space and pricing power even in a tougher retail environment. This brand trust gives the company steady cash flow and resilience during downturns.
Management’s ongoing cost-saving and productivity programs also provide a buffer. The company reaffirmed its efficiency target for 2025 and continues to reinvest in innovation to refresh its product portfolio. Emerging markets are another bright spot, with growth in Asia and Latin America helping to offset slower sales in developed regions.
For investors, these strengths suggest Kimberly-Clark still has the tools to protect profitability and maintain dividend stability even in a sluggish demand backdrop.
Bear Case: Shrinking Growth and Valuation Pressure
Even with these positives, Kimberly-Clark’s growth profile remains soft. The company’s mature product categories offer limited pricing flexibility, and volume recovery has been slow.
At about 16x forward earnings, valuation is reasonable but not cheap given the weak outlook. If inflation pressures persist or private-label competition intensifies, margins could stay under pressure longer than expected.
For investors, the risk is that KMB’s defensive appeal may not translate into meaningful returns. Without stronger top-line momentum, the stock could lag peers with higher growth potential.
Outlook for 2027: What Could Kimberly-Clark Be Worth?
Based on analysts’ average estimates, TIKR’s Guided Valuation Model using a 15.6x forward P/E suggests KMB could trade near $118/share by 2027. That represents about a (1%) total return from today’s level, or roughly (0.6%) annualized.
While this outcome implies stability, it also shows that the market expects limited improvement ahead. To deliver upside beyond these projections, Kimberly-Clark would need stronger volume recovery or faster cost savings than analysts currently expect.
For investors, KMB looks like a steady dividend stock that provides income reliability but not significant price appreciation unless growth trends improve.
AI Compounders With Massive Upside That Wall Street Is Overlooking
Everyone wants to cash in on AI. But while the crowd chases the obvious names benefiting from AI like NVIDIA, AMD, or Taiwan Semiconductor, the real opportunity may lie on the AI application layer where a handful of compounders are quietly embedding AI into products people already use every day.
TIKR just released a new free report on 5 undervalued compounders that analysts believe could deliver years of outperformance as AI adoption accelerates.
Inside the report, you’ll find:
- Businesses already turning AI into revenue and earnings growth
- Stocks trading below fair value despite strong analyst forecasts
- Unique picks most investors haven’t even considered
If you want to catch the next wave of AI winners, this report is a must-read.
Click here to sign up for TIKR and get your free copy of TIKR’s 5 AI Compounders report today.